Please ensure Javascript is enabled for purposes of website accessibility

Why Chesapeake Energy Stock Is Skyrocketing Today

By Matthew DiLallo – Apr 24, 2020 at 12:16PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The beleaguered oil and gas driller is taking steps to protect its lucrative losses.

What happened

Shares of Chesapeake Energy (CHKA.Q) are skyrocketing today, up by more than 37% as of 10:30 a.m. EDT, following news that the oil and gas specialist adopted a poison pill to shield its "net operating loss carryforwards" (NOLs) from a potential acquirer.  

So what

Chesapeake Energy's board of directors has adopted a shareholder rights plan, also known as a poison pill, to protect the availability of its NOLs. The company had racked up about $7.6 billion of NOLs as of the end of last year that it could use to offset future federal income taxes. These NOLs are the result of years of losses, as Chesapeake has struggled to turn a profit due to mismanagement and commodity price volatility.  

Two oil pumps with a bright sun in the background.

Image source: Getty Images.

NOLs are potentially valuable to a would-be acquirer because it could use them to offset its future tax liability. Chesapeake, however, has taken a step to protect this value by adopting a shareholder rights plan. Under this poison pill, Chesapeake's ability to use these NOLs would be significantly limited if it experienced an ownership change. That would happen if investors holding 5% of its stock increased their ownership by more than 50% over a rolling three-year period. In this case, if an investor or group acquires 4.9% or more of Chesapeake's outstanding stock, the rest of the company's investors would be able to purchase shares at a 50% discount. That would dilute the holdings of the 5% investor, making it harder for them to wrestle control of the company for its NOLs.  

Now what

Speculators see the adoption of a poison pill as an indication that an investor (such as a hedge fund) might want to take control of Chesapeake. That seems highly unlikely given the energy company's massive $9 billion debt. This leverage has put so much financial strain on Chesapeake that it seems destined to file for bankruptcy in the coming months. The most likely outcome of that event would be the complete wipeout of the company's existing shareholders. That high probability of a worthless stock is why investors should steer clear of Chesapeake.

Matthew DiLallo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Chesapeake Energy Corporation Stock Quote
Chesapeake Energy Corporation
CHKA.Q

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
342%
 
S&P 500 Returns
107%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.